Seraxis

Seraxis is a private biotechnology company launched in March 2013 with investment from angel investors, an investment fund and a VC firm. Incorporated in Singapore and the US, our GMP lab is located in Germantown, Maryland. Seraxis used proprietary technologies to develop: (1) a cell therapy that is more effective and safer than embryonic stem cell-derived therapies, and; (2) cell microencapsulation that enables the function of human pancreas cells in normal animals.